These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3585142)

  • 1. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
    Baughman RP; Mangels DJ; Strohofer S; Corser BC
    J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity.
    Baughman RP; Strohofer S
    J Clin Lab Immunol; 1989 Feb; 28(2):51-4. PubMed ID: 2787406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
    Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
    Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity of human pulmonary alveolar macrophages.
    Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
    Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
    Weinberg JB; Haney AF
    J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.
    Barna BP; Thomassen MJ; Wiedemann HP; Ahmad M; Deodhar SD
    J Biol Response Mod; 1988 Oct; 7(5):483-7. PubMed ID: 3183685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar macrophage and blood monocyte function in lung cancer.
    Hosker HS; Corris PA
    Cancer Detect Prev; 1991; 15(2):103-6. PubMed ID: 2032250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation.
    Andreesen R; Osterholz J; Bross KJ; Schulz A; Luckenbach GA; Löhr GW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5931-6. PubMed ID: 6357433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human alveolar macrophages: wheat germ agglutinin-dependent tumor cell killing.
    Ogawara M; Sone S; Ogura T
    Jpn J Cancer Res; 1987 Mar; 78(3):288-95. PubMed ID: 3106285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of natural killer activity by human bronchoalveolar macrophages.
    Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
    J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
    Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
    J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
    Swinburne S; Cole P
    J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of alveolar macrophages from patients with metastatic renal cell carcinoma.
    Thomassen MJ; Barna BP; Wiedemann HP; Bukowski RM; Farmer M; Ahmad M
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1256-8. PubMed ID: 2339845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
    McLennan G; Gill PG; De Young NJ
    J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity.
    Perri RT; Vercellotti G; McCarthy J; Vessella RL; Furcht LT
    J Lab Clin Med; 1985 Jan; 105(1):30-5. PubMed ID: 3968463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alveolar macrophages in tumor-bearing rats: tumoricidal properties of carrageenan-activated macrophages.
    Bijma AM; Stehmann TE; Weijma IM; Kort WJ
    Invasion Metastasis; 1988; 8(6):364-73. PubMed ID: 3225148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
    Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
    Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.